News Release

ESMO Gynaecological Cancers Congress 2023

23-24 February in Barcelona, Spain and online

Meeting Announcement

European Society for Medical Oncology

Lugano, Switzerland, 10 February 2023 – The ESMO Gynaecological Cancers Congress 2023, the annual event dedicated to improving the practice of gynaecological cancers specialists worldwide, will provide an overview of the latest treatments as well as insights into the biology and biomarkers of ovarian, uterine, cervical and even rare gynaecological cancers. 

The event will be held in person in Barcelona, Spain, and online, through a virtual platform, on 23-24 February 2023. 

Programme highlights  

  • Understanding the molecular profiles of endometrial cancer to foster personalised treatment strategies beyond immunotherapy 
    Session: Endometrial cancer 

  • Individually rare, but collectively common: New insights on therapeutic options for rare gynaecological cancers  
    Session: Multidisciplinary tumour board: Rare cancers 

The results of around 80 studies will be presented either as mini oral or posters, and published online as a supplement of Annals of Oncology. The abstract titles can be viewed through the online programme

Keynote lecture 

Media registration 
ESMO welcomes media interested in obtaining information and reporting on cancer issues. Only through the official accreditation process with the media registration form, accredited media representatives will be able to access (both in person and virtually): scientific and educational sessions, poster area and e-posters, exhibition and industry satellite symposia, congress webcasts, embargoed material.  

Further information  
ESMO Press Office  


Notes to Editors  
Please make sure to use the official name of the meeting in your reports: ESMO Gynaecological Cancers Congress 2023 
and the official congress hashtag:  #ESMOGynae23 

Follow the conversation on Twitter, LinkedInInstagramFacebook 


About the European Society for Medical Oncology (ESMO)   
ESMO is the leading professional organisation for medical oncology. With more than 28,000 members representing oncology professionals from 160 countries worldwide, ESMO is the society of reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. Visit  

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.